Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Rebamipida")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 78

  • Page / 4
Export

Selection :

  • and

Rebamipide Suppresses Polyl:C-Stimulated Cytokine Production in Human Conjunctival Epithelial CellsUETA, Mayumi; SOTOZONO, Chie; YOKOI, Norihiko et al.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 7, pp 688-693, issn 1080-7683, 6 p.Article

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liverKOYAMA, N; SASABE, . H; MIYAMOTO, G et al.Xenobiotica (London. Print). 2002, Vol 32, Num 7, pp 573-586, issn 0049-8254Article

Intravesical Application of Rebamipide Suppresses Bladder Inflammation in a Rat Cystitis ModelFUNAHASHI, Yasuhito; YOSHIDA, Masaki; YAMAMOTO, Tokunori et al.The Journal of urology. 2014, Vol 191, Num 4, pp 1147-1152, issn 0022-5347, 6 p.Article

Rebamipide Increases Mucin-Like Substance Contents and Periodic Acid Schiff Reagent-Positive Cells Density in Normal RabbitsURASHIMA, Hiroki; TAKEJI, Yasuhiro; OKAMOTO, Takashi et al.Journal of ocular pharmacology and therapeutics. 2012, Vol 28, Num 3, pp 264-270, issn 1080-7683, 7 p.Article

Gastric Ulcerogenic and Healing Impairment Actions of Alendronate, A Nitrogen-Containing Bisphosphonate - Prophylactic Effects of RebamipideTAKEUCHI, Koji; KATO, Shinichi; AMAGASE, Kikuko et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 16, pp 1602-1611, issn 1381-6128, 10 p.Article

Management of Recurrence of Symptoms of Gastroesophageal Reflux Disease: Synergistic Effect of Rebamipide with 15 mg LansoprazoleYOSHIDA, Norimasa; KAMADA, Kazuhiro; TOMATSURI, Naoya et al.Digestive diseases and sciences. 2010, Vol 55, Num 12, pp 3393-3398, issn 0163-2116, 6 p.Article

Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse modelBANG, Dongsik; CHOI, Bunsoon; HYUK JAE KWON et al.European journal of pharmacology. 2008, Vol 598, Num 1-3, pp 112-117, issn 0014-2999, 6 p.Article

A pilot study to evaluate a new combination therapy for gastric ulcer : Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipideTERANO, Akira; ARAKAWA, Tetsuo; TAKAHASHI, Shin-Ichi et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 1, pp 103-109, issn 0815-9319, 7 p., 1Article

Rebamipide reduces recurrence of experimental gastric ulcers : Role of free radicals and neutrophilsSAKURAI, Kazushi; OSAKA, Toshihiro; YAMASAKI, Katsuya et al.Digestive diseases and sciences. 2005, Vol 50, pp S90-S96, issn 0163-2116, SUP1Article

Effect of long-term administration of rebamipide on Helicobacter pylori infection in miceHAHM, K. B; KIM, D. H; NAM, K. T et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, pp 24-38, issn 0269-2813, 15 p., SUP1Conference Paper

Rebamipide binds to iNOS-positive cells in acetic acid-treated but not in ethanol-treated rat gastric mucosaNAKAMURA, M; AKIBA, Y; MATSUI, H et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, pp 76-81, issn 0269-2813, 6 p., SUP1Conference Paper

Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipideHAHM, K. B; LEE, K. J; KIM, Y. S et al.Digestive diseases and sciences. 1998, Vol 43, Num 2, pp 235-240, issn 0163-2116Article

Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in ratsMURAKAMI, K; OKAJIMA, K; HARADA, N et al.Digestive diseases and sciences. 1998, Vol 43, Num 9, pp 139S-142S, issn 0163-2116, SUPConference Paper

Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled studyNAITO, Y; YOSHIKAWA, T; IINUMA, S et al.Digestive diseases and sciences. 1998, Vol 43, Num 9, pp 83S-89S, issn 0163-2116, SUPConference Paper

Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in ratsMURAKAMI, K; OKAJIMA, K; UCHIBA, M et al.Digestive diseases and sciences. 1997, Vol 42, Num 2, pp 319-325, issn 0163-2116Article

Effects of rebamipide on bile acid-induced inhibition of gastric epithelial repair in a rabbit cell culture modelWATANABE, S; WANG, X.-E; HIROSE, M et al.Alimentary pharmacology & therapeutics. 1996, Vol 10, Num 6, pp 927-932, issn 0269-2813Article

Effect of rebamipide on the colonic barrier in interleukin-10-deficient miceLAHARIE, David; MENARD, Sandrine; ASENCIO, Corinne et al.Digestive diseases and sciences. 2007, Vol 52, Num 1, pp 84-92, issn 0163-2116, 9 p.Article

Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia : A double-blind placebo-controlled study in JapanMIWA, Hiroto; OSADA, Taro; NAGAHARA, Akihito et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 12, pp 1826-1831, issn 0815-9319, 6 p.Article

Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in ratsBEOM SOO SHIN; CHUL HWAN KIM; YOON SIK JUN et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 8, pp 869-876, issn 0363-9045, 8 p.Article

Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cellsSEOK JUN MOON; JEONG MI AN; KIM, Juyeon et al.European journal of pharmacology. 2004, Vol 505, Num 1-3, pp 61-66, issn 0014-2999, 6 p.Article

Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infectionADACHI, Kyoichi; FUJISHIRO, Hirofumi; MIHARA, Takafumi et al.Journal of gastroenterology and hepatology. 2003, Vol 18, Num 2, pp 168-171, issn 0815-9319, 4 p.Article

Radical scavengers for Ménière's disease after failure of conventional therapy: A pilot studyTAKUMIDA, Masaya; ANNIKO, Matti; OHTANI, Makiko et al.Acta oto-laryngologica. 2003, Vol 123, Num 6, pp 697-703, issn 0001-6489, 7 p.Article

Effect of rebamipide on prostaglandin receptors-mediated increase of inflammatory cytokine production by macrophagesRAMBA, H; OTA, S; KATO, A et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, pp 113-118, issn 0269-2813, 6 p., SUP1Conference Paper

Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipideTAKAHASHI, M; TAKADA, H; TAKAGI, K et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, pp 126-132, issn 0269-2813, 7 p., SUP1Conference Paper

Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipideFARHADI, A; KESHAVARZIAN, A; FITZPATRICK, L. R et al.Digestive diseases and sciences. 2002, Vol 47, Num 6, pp 1342-1348, issn 0163-2116Article

  • Page / 4